Global Pure Cortical Bone Granules Market Insights, Forecast to 2028

Market Analysis and Insights: Global Pure Cortical Bone Granules Market
Due to the COVID-19 pandemic, the global Pure Cortical Bone Granules market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, 500μm–1000μm accounting for % of the Pure Cortical Bone Granules global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Pure Cortical Bone Granules market size is valued at US$ million in 2021, while the US and Europe Pure Cortical Bone Granules are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Pure Cortical Bone Granules landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Pure Cortical Bone Granules include Zimmer Biomet, MiMedix Group, Allergan, CONMED, RTI Surgical, Lattice Biologics, B. Braun, AlonSource and Guanhao Biotech and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Pure Cortical Bone Granules Scope and Segment
Pure Cortical Bone Granules market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Pure Cortical Bone Granules market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
500μm–1000μm
1000μm–1500μm
Other
Segment by Application
Hospital
Orthopedics Clinic
Other
By Company
Zimmer Biomet
MiMedix Group
Allergan
CONMED
RTI Surgical
Lattice Biologics
B. Braun
AlonSource
Guanhao Biotech
Topchoice Medical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE